NHS Framework for the North of England, Branded Medicine
NHS England · London
Key facts
- Awarded
- 07 Feb 2022
- Contract starts
- 01 Mar 2022
- Contract ends
- 29 Feb 2024
- Procedure
- Open procedure (above threshold)
- Buyer type
- Central government
Awarded to 31 suppliers
| Supplier | Value |
|---|---|
| Takeda UK Limited | — |
| CST Pharma Ltd | — |
| GlaxoSmithKline | — |
| Janssen-Cilag Ltd | — |
| Pfizer Ltd | — |
| Teva UK Ltd | — |
| Bayer plc | — |
| Amgen Ltd | — |
| Aventis Pharma Ltd T/A Sanofi | — |
| Napp Pharmaceuticals | — |
| Sandoz Ltd | — |
| Thornton & Ross Ltd | — |
| Accord-UK Ltd | — |
| AstraZeneca | — |
| Biogen | — |
| Celltrion Healthcare United Kingdom Limited | — |
| Eli Lilly & Company Ltd | — |
| Gedeon Richter UK Ltd | — |
| Gilead Sciences Limited | — |
| Ipsen | — |
| Merck Serono Limited | — |
| Merck Sharpe & Dohme (UK) Limited | — |
| Mylan | — |
| Novo Nordisk | — |
| Organon Pharmaceuticals UK Ltd | — |
| Roche Products Ltd | — |
| Sobi (Swedish Orphan Biovitrum Ltd) | — |
| UCB Pharma Ltd | — |
| Zentiva Pharma UK Ltd | — |
| Bristol Myers Squibb | — |
| UL Global Pharma | — |
Description
Offer reference number: CM/PHR/20/5600 CM/PHR/20/5600/01 - NHS Framework for the North of England, Branded Medicines -Tranche B - 1 March 2022 to 29 February 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/20/5600/02 - NHS Framework for the North of England, Branded Medicines - Annual Tranche Products. Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. CM/PHR/20/5600/03- NHS Framework for Insulin Aspart Biosimilar (Trurapi®), South of England - Period of framework: 1 March 2022 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. CM/PHR/20/5600/04 - NHS Framework for Insulin Aspart Biosimilar (Trurapi®), London - Period of framework: 1 March 2022 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/20/5600/05 - NHS Framework for Insulin Aspart Biosimilar (Trurapi®), Midlands and East - Period of framework: 1 March 2022 to 28 February 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
Categories (CPV)
- 33600000 Pharmaceutical products
Similar open tenders
Theatre/ENT Dental
Location: West MidlandsBuyer: The Shrewsbury and Telford Hospital NHS Trust
Open tenderCloses 13 Nov, 20268 daysValue £100.00kSource Find a TenderTheatre/ENT Dental Consumables
Global Travel, Accommodation and Venue Management Services
Location: North WestBuyer: Government Commercial Agency
Open tenderCloses 8 Dec, 202633 daysValue £36.25bnSource Find a TenderA framework providing comprehensive booking solutions for all UK Public Sector Travel needs, including air, rail, taxis, coaches, car hire, accommodation and venues for meetings, conferences and events, as well as emergency travel and accommodation solutions, including for civilian cohorts under the care of a UK Public
Orthotic Splints & Braces
Location: West MidlandsBuyer: The Shrewsbury and Telford Hospital NHS Trust
Open tenderCloses 13 Nov, 20268 daysValue £60.14kSource Find a TenderOrthotic Splints & Braces - RJAH, SATH , SCT
UKRI-6412 MRC Harwell Self-Steam Generating Autoclave
Location: South WestBuyer: UK Research & Innovation (UKRI)
Open tenderCloses 30 Nov, 202625 daysValue £150.00kSource Find a TenderMRC Harwell is seeking to replace the existing autoclave with the supply, installation and acceptance of a self-steaming generating autoclave
Cleanroom Consumables
Location: West MidlandsBuyer: The Shrewsbury and Telford Hospital NHS Trust
Open tenderCloses 9 Nov, 20264 daysValue £11.91kSource Find a TenderCleanroom Consumables - SATH & SCT
MED0014 - The Supply of Beating Heart Products
Location: United KingdomBuyer: University Hospitals of North Midlands NHS Trust
Open tenderCloses 16 Nov, 202611 daysValue £18.33kSource Find a TenderBeating heart surgery (Off-Pump Coronary Artery Bypass or OPCAB) utilizes specific stabilization equipment rather than a cardiopulmonary bypass machine.